You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic Pancreatic Adenocarcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer Of Pancreas Trial (Analyze of GemCore status)

Not yet recruiting
  • Cancer Of Pancreas
  • Analyze of GemCore status
  • (no location specified)
Sep 19, 2023

Metastatic Pancreatic Adenocarcinoma Trial (Avelumab and Pepinemab)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Avelumab and Pepinemab
  • Rochester, New York
    University of Rochester Medical Center
Jan 19, 2023

Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Enfortumab vedotin
  • Kansas City, Kansas
    University of Kansas Cancer Center
Jun 23, 2023

Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • +12 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 30, 2022

PDAC - Pancreatic Ductal Adenocarcinoma Trial (Combination of sitagliptin+ gemcitabine + nab-paclitaxel)

Not yet recruiting
  • PDAC - Pancreatic Ductal Adenocarcinoma
  • Combination of sitagliptin+ gemcitabine + nab-paclitaxel
  • (no location specified)
Jul 9, 2023

Metastatic Pancreatic Adenocarcinoma Trial in Ann Arbor (Devimistat, Modified FOLFIRINOX)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Ann Arbor, Michigan
    Rogel Cancer Center
Jun 26, 2023

Metastatic Pancreatic Adenocarcinoma Trial in Shanghai (Ascorbate, Nab paclitaxel, Gemcitabine)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Shanghai, Shanghai, China
    Shanghai Cancer Center
Aug 29, 2023

Metastatic Pancreatic Cancer Trial (nanoliposomal irinotecan, spleen irradiation)

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • nanoliposomal irinotecan
  • spleen irradiation
  • (no location specified)
May 8, 2022

Adenocarcinoma of the Pancreas Trial in Italy, Spain (Valproic acid, Simvastatin 20mg, Gemcitabine 1000 mg)

Not yet recruiting
  • Adenocarcinoma of the Pancreas
  • Valproic acid
  • +4 more
  • Milano, Italy
  • +4 more
Apr 6, 2023

Pancreas Cancer Trial in Fribourg (Bazedoxifene 20 mg)

Recruiting
  • Pancreas Cancer
  • Bazedoxifene 20 mg
  • Fribourg, Switzerland
    HFR Fribourg - cantonal hospital
Feb 9, 2022

Metastatic Pancreatic Adenocarcinoma Trial (Ivaltinostat, Capecitabine)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • (no location specified)
Feb 10, 2022

Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)

Recruiting
  • Pancreas Cancer
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Aug 19, 2022

Metastatic Pancreatic Adenocarcinoma Trial (odetiglucan, CDX-1140)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • odetiglucan
  • CDX-1140
  • (no location specified)
Jul 29, 2022

Pancreatic Cancer Trial in Baltimore (Tadalafil, Pembrolizumab, Ipilimumab)

Recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Aug 23, 2022

Advanced Pancreatic Cancer Trial in Baltimore (galeterone, Gemcitabine)

Recruiting
  • Advanced Pancreatic Cancer
  • Baltimore, Maryland
    University of Maryland Medical Center
Mar 10, 2022

Metastatic Pancreatic Adenocarcinoma Trial in United States (Nivolumab (Cohort A), Ipilimumab (Cohort A and B),

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Nivolumab (Cohort A)
  • +4 more
  • Los Angeles, California
  • +6 more
Aug 8, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Japan (ASP2138)

Recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Santa Monica, California
  • +5 more
Dec 13, 2022

Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (BXCL701, Pembrolizumab)

Not yet recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Jan 23, 2023

Pancreas Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Jacksonville (Modified GCN+TTF treatment)

Recruiting
  • Pancreas Cancer
  • +3 more
  • Modified GCN+TTF treatment
  • Jacksonville, Florida
    Mayo Clinic
Apr 4, 2022

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

Not yet recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Nab paclitaxel
  • +5 more
  • (no location specified)
Oct 30, 2023

Pancreatic Cancer Trial (TTX-030, nab-paclitaxel and gemcitabine, TTX-030, budigalimab, nab-paclitaxel and gemcitabine,

Not yet recruiting
  • Pancreatic Cancer
  • TTX-030, nab-paclitaxel and gemcitabine
  • +2 more
  • (no location specified)
Nov 3, 2023

Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in

Not yet recruiting
  • Pancreatic Adenocarcinoma Metastatic
    • Pessac, France
      CHU Bordeaux
    Aug 17, 2023

    Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • Washington, District of Columbia
      Lombardi Comprehensive Cancer Center, Georgetown University
    Apr 11, 2023

    Metastatic Pancreatic Adenocarcinoma Trial in Cleveland (Regorafenib, Gemcitabine Hydrochloride)

    Terminated
    Has Results
    • Metastatic Pancreatic Adenocarcinoma
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Jun 1, 2022

    Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • Durvalumab
    • Rintatolimod
    • Rotterdam, Zuid-Holland, Netherlands
      Erasmus MC
    Jun 23, 2023